More on FLML

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (10.0 Score)
- Holders
- FDA Archive

Financials

Income Statement
Balance Sheet
Cash Flow Statement

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

FLML Balance Sheet

Click line-items for a historical chart and %
Cash and cash equivalents 18.78M
Marketable securities 130.89M
Accounts receivable (net of allowance of $35 and $127 at December 31, 2015 and 2014 respectively) 15.4M
Inventories 3.91M
Research and development tax credit receivable - current portion 0
Prepaid expenses and other current assets 8.88M
Current assets held for sale
Total current assets 177.85M
Property and equipment, net 3.19M
Goodwill 19.13M
Intangible assets, net 25.51M
Income tax deferred charge 11.24M
Other 6.82M
Total assets 247.99M
Current portion of long-term debt 286K
Current portion of long-term related party contingent consideration payable
Accounts payable 8.97M
Deferred revenue 3.12M
Accrued expenses 13.03M
Income taxes
Other 427K
Current liabilities held for sale
Total current liabilities 59.19M
Long-term debt, less current portion 734K
Long-term related party contingent consideration payable, less current portion
Deferred taxes
Other 4.31M
Total liabilities 211.15M
Ordinary shares, nominal value of 0.122 euro per share; 53,198 shares authorized; 41,241 and 40,191 issued and outstanding at December 31, 2015 and 2014, respectively 6.33M
Additional paid-in capital 374.72M
Accumulated deficit -324.53M
Accumulated other comprehensive loss -19.69M
Total shareholders' equity 36.83M
Total liabilities and shareholders' equity 247.99M